Absolutely.
In terms of the watch-list, this is really moving towards a hazard-based approach, in addition to being redundant with the existing mechanisms in place to control existing substances. They have been determined as acceptable on the market as is, but if new uses come up for these substances, then there are those control mechanisms to address and assess that situation.